MHLW Designates UMN-0501 And Forodesine Hydrochloride Orphan Drugs
This article was originally published in PharmAsia News
Executive Summary
The Drug and Food Board of the Ministry of Health, Labor and Welfare designated UMN Pharma's UMN-0501 and MundiPharma's forodesine hydrochloride orphan drugs during a May 23 session.UMN-0501 is a pandemic influenza vaccine produced by recombinant protein expression. Compared to the current flu vaccines that are produced using eggs, UMN-0501 enables production in larger quantities and shorter time periods. It also has fewer side effects such as allergies, anaphylactic shock and Guilain-Barre syndrome. Forodesine hydrochloride is used to treat relapsing and intractable T-cell lymphoma, and adult T-cell leukemia. (Click here for more - Japanese language